Hyperresistance to 4-nitroquinoline 1-oxide cytotoxicity and reduced DNA damage formation in dermal fibroblast strains derived from five members of a cancer-prone family
1993

Resistance to a Carcinogen in Cancer-Prone Family Members

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): R. Mirzayans, M. Sabour, A.M. Rauth, M.C. Paterson

Primary Institution: Cross Cancer Institute, Edmonton, Alberta

Hypothesis

Do fibroblast strains from a cancer-prone family exhibit abnormal resistance to the cytotoxic effects of 4-nitroquinoline 1-oxide?

Conclusion

Fibroblast strains from a cancer-prone family show significant resistance to 4-nitroquinoline 1-oxide due to reduced drug accumulation and enzymatic activity.

Supporting Evidence

  • Cells from the cancer-prone family showed 1.8 to 4.3 times greater resistance to 4NQO than normal controls.
  • 4NQO-resistant strains had lower DNA damage and repair synthesis compared to normal fibroblasts.
  • Some strains exhibited normal sensitivity to UV light and other genotoxic agents.

Takeaway

Some family members with a history of cancer have skin cells that are tougher against a harmful chemical than normal cells.

Methodology

Fibroblast strains were compared for sensitivity to 4-nitroquinoline 1-oxide and other genotoxic agents, measuring DNA damage and repair.

Potential Biases

Potential bias due to the selection of family members with known cancer history.

Limitations

The study is limited to a small sample size from one family, which may not represent broader populations.

Participant Demographics

Five members of a cancer-prone family, including a sister, mother, aunts, and an uncle.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication